QUERCIVA

Tesseract Medical Research, LLC

Application Filed: 2017-06-23

Trademark Application Details

Status

731

Live/Pending

SECOND EXTENSION - GRANTED

Research	OneLook Acronym Finder
Serial Number	87503663
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Kim R. Pearson
Law Office Assigned	N40
Employee Name	WINTER, MELISSA S

Timeline

2017-06-23	Application Filed
2018-04-24	Published for Opposition
2019-08-07	Location: INTENT TO USE SECTION
2019-08-07	Status: Live/Pending
2019-12-19	Transaction Date

Trademark Applicants & Owners

Owner:	Tesseract Medical Research, LLC
Address	1370 Trancas Street, Suite 350 Napa DE 94558
Legal Entity Type	Limited Liability Company
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

KIM R. PEARSON
103 Noisette Row
Summerville, SC 29483

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing quercetin; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of food supplements, namely, antioxidants for increasing quercetin in the body for supporting respiratory function, promoting stabilization of mast cell membranes, modulating histamine release, and optimizing cytokine profiles; functional nutrient preparations containing quercetin to mitigate histamine release, inflammatory response, and oxidation of LDL cholesterol; specialty nutraceuticals for the dietary management of diseases, disorders, and adverse health conditions that can be remediated with quercetin, namely, exaggerated immune response, exaggerated inflammatory response, and hyperimmune reactions

Type Code

Type

GS0051

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing quercetin; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of food supplements, namely, antioxidants for increasing quercetin in the body for supporting respiratory function, promoting stabilization of mast cell membranes, modulating histamine release, and optimizing cytokine profiles; functional nutrient preparations containing quercetin to mitigate histamine release, inflammatory response, and oxidation of LDL cholesterol; specialty nutraceuticals for the dietary management of diseases, disorders, and adverse health conditions that can be remediated with quercetin, namely, exaggerated immune response, exaggerated inflammatory response, and hyperimmune reactions

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2017-06-27	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2017-06-30	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2017-09-21	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2017-09-28	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2017-09-28	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2017-09-28	6 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2018-02-21	7 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2018-02-21	8 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2018-02-21	9 TEME I:Incoming Correspondence
EXAMINERS AMENDMENT -WRITTEN	2018-03-21	10 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2018-03-21	11 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2018-03-21	12 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2018-03-21	13 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2018-03-21	14 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2018-04-04	15 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2018-04-24	16 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2018-04-24	17 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2018-06-19	18 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2018-12-15	19 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2018-12-15	20 EXT1 S:
EXTENSION 1 GRANTED	2018-12-15	21 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2018-12-18	22 EXRA E:E-Mail
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2019-06-25	23 TCCA I:Incoming Correspondence
TEAS PETITION TO REVIVE RECEIVED	2019-06-25	24 PROA I:Incoming Correspondence
PETITION TO REVIVE-GRANTED	2019-06-25	25 PETG O:Outgoing Correspondence
EXTENSION RECEIVED WITH TEAS PETITION	2019-06-25	26 TPEX I:Incoming Correspondence
NOTICE OF REVIVAL - E-MAILED	2019-06-26	27 NREV E:E-Mail
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2019-08-07	28 AITU A:Allowance for Publication
EXTENSION 2 FILED	2019-06-19	29 EXT2 S:
EXTENSION 2 GRANTED	2019-08-07	30 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-08-08	31 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2020-01-20	32 ABN6 S:
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2020-01-21	33 MAB6 E:E-Mail
TEAS PETITION TO REVIVE RECEIVED	2020-03-21	34 PROA I:Incoming Correspondence
PETITION TO REVIVE-GRANTED	2020-03-21	35 PETG O:Outgoing Correspondence
EXTENSION RECEIVED WITH TEAS PETITION	2020-03-21	36 TPEX I:Incoming Correspondence
NOTICE OF REVIVAL - E-MAILED	2020-03-21	37 NREV E:E-Mail
EXTENSION 3 FILED	2019-12-19	38 EXT3 S:
EXTENSION 3 GRANTED	2020-03-23	39 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-03-24	40 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2020-07-20	41 ABN6 S:
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2020-07-20	42 MAB6 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.